Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study

• Published in: Cancer causes & control 2024-04, Vol.35 (4), p.647-659
• Main Authors: Pandit, Ambrish A., Halpern, Michael T., Gressler, Laura E, Kamel, Mohamed, Payakachat, Nalin, Li, Chenghui
• Format: Article
• Language: English
• Subjects: Aged; Biomedical and Life Sciences; Biomedicine; Cancer Research; Cancer Survivors; Diagnosis; Epidemiology; Ethnicity; Government programs; Hematology; Humans; Male; Medicare; Minority & ethnic groups; Older people; Oncology; Original Paper; Patient Care; Patients; Physicians; Prostate; Prostate cancer; Prostatic Neoplasms - epidemiology; Public Health; SEER Program; Survivor; United States - epidemiology
• ISSN: 0957-5243; 1573-7225
• DOI: 10.1007/s10552-023-01834-4

Purpose This study aimed to evaluate the association of race/ethnicity, patient care experiences (PCEs), and receipt of definitive treatment and treatment modality among older adults in the United States (US) with localized prostate cancer (PCa). Methods Using Surveillance, Epidemiology and End Results dataset linked to Medicare Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS) for 2007–2015, we identified men aged ≥ 65 years who completed a CAHPS survey within one year before and one year after PCa diagnosis. Associations of race/ethnicity (non-Hispanic White (NHW), non-Hispanic Black (NHB), Hispanic, non-Hispanic Asian (NHA), and other) and of interactions between race/ethnicity and PCEs (getting needed care, getting care quickly, doctor communication, and care coordination) with the receipt of definitive PCa treatment and treatment modality within 3 and 6 months of diagnosis were examined using logistic regressions. Results Among 1,438 PCa survivors, no racial/ethnic disparities in the receipt of definitive treatment were identified. However, NHB patients were less likely to receive surgery (vs. radiation) within 3 and 6 months of PCa diagnosis than NHW patients (OR 0.397, p  = 0.006 and OR 0.419, p  = 0.005), respectively. Among NHA patients, a 1-point higher score for getting care quickly was associated with lower odds (OR 0.981, p  = 0.043) of receiving definitive treatment within 3 months of PCa diagnosis, whereas among NHB patients, a 1-point higher score for doctor communication was associated with higher odds (OR 1.023, p  = 0.039) of receiving definitive treatment within 6 months of PCa diagnosis. Discussion We observed differential associations between PCEs and receipt of definitive treatment based on patient race/ethnicity. Further research is needed to explore these associations.